Anpario (LON:ANP) Receives “House Stock” Rating from Shore Capital

Anpario (LON:ANP)‘s stock had its “house stock” rating reissued by research analysts at Shore Capital in a research note issued on Monday,Digital Look reports.

Separately, Canaccord Genuity Group lifted their price target on Anpario from GBX 500 to GBX 550 and gave the stock a “buy” rating in a research note on Tuesday, October 21st. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of GBX 550.

Anpario Price Performance

Shares of LON ANP traded up GBX 44.50 during mid-day trading on Monday, reaching GBX 516. The company had a trading volume of 105,467 shares, compared to its average volume of 27,871. The company has a 50-day moving average price of GBX 488.29 and a two-hundred day moving average price of GBX 459.09. The stock has a market cap of £87.44 million, a PE ratio of 17.36 and a beta of 0.58. The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.10. Anpario has a 1-year low of GBX 286 and a 1-year high of GBX 536.50.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.